Background-The negative effect of tumor necrosis factor-␣ (TNF-␣) on heart contraction, which is mediated by sphingosine, is a major component in heart failure. Because the cellular level of glutathione may limit sphingosine production via the inhibition of the Mg-dependent neutral sphingomyelinase (N-SMase), we hypothesized that cardiac glutathione status might determine the negative contractile response to TNF-␣. Methods and Results-We examined the effects of TNF-␣ in isolated cardiomyocytes obtained from control rats or rats that were given the glutathione precursor N-acetylcysteine (NAC, 100 mg IP per animal). In cardiomyocytes obtained from control rats, 25 ng/mL TNF-␣ increased reactive oxygen species generation and N-SMase activity (500% and 34% over basal, respectively) and decreased the amplitude of [Ca 2ϩ ] i in response to electrical stimulation (22% below basal). NAC treatment increased cardiac glutathione content by 42%. In cardiomyocytes obtained from NAC-treated rats, 25 ng/mL TNF-␣ had no effect on reactive oxygen species production or N-SMase activity but increased the amplitude of [Ca 2ϩ ] i transients and contraction in response to electrical stimulation by 40% to 50% over basal after 20 minutes. This was associated with a hastened relaxation (20% reduction in t 1/2 compared with basal) and an increased phosphorylation of both Ser 16 -and Thr 17 -phospholamban residues (260% and 115% of maximal isoproterenol effect, respectively). Conclusions-It is concluded that cardiac glutathione status, by controlling N-SMase activation, determines the severity of the adverse effects of TNF-␣ on heart contraction. Glutathione supplementation may therefore provide therapeutic benefits for vulnerable hearts. (Circulation. 2004;109:406-411.) 
H igh expression in the myocardium and high levels in serum of the proinflammatory cytokine tumor necrosis factor-␣ (TNF-␣) are causally linked to the progression of heart failure. [1] [2] [3] [4] TNF-␣ exerts a dual effect on heart contraction 5,6 that we could reproduce in isolated, electrically stimulated adult rat cardiomyocytes. At low concentrations, TNF-␣ increases the amplitude of [Ca 2ϩ ] i transients and contraction in response to electrical stimulation, whereas at high concentrations, it impairs electrically stimulated [Ca 2ϩ ] i transients and contraction. 7 The negative inotropic effect of TNF-␣ relies on arachidonic acid, released on activation of the cytosolic phospholipase A 2 , and sphingosine. 7, 8 We proposed that sphingosine was produced by downstream ceramide production after activation by arachidonic acid of the Mg-dependent neutral sphingomyelinase (N-SMase). 7 In such a hypothesis, under conditions in which N-SMase activation would be impaired, the negative effect of high TNF-␣ concentrations should be abrogated. Furthermore, the positive effect on [Ca 2ϩ ] i transients and contraction, which is detectable at low TNF-␣ concentrations and is not mediated by sphingosine, might be unmasked.
Heart failure is associated with oxidative stress and depletion in the tripeptide glutathione, which ensures the maintenance of cell redox status. 9 Independently of the reduced/oxidized glutathione ratio (GSH/GSSG), cellular glutathione depletion stimulates N-SMase activity. 10 -12 The aim of the present study was therefore to look for a possible link between cardiac glutathione content, N-SMase activity, and the contractile response to TNF-␣. We examined reactive oxygen species (ROS) generation, N-SMase activity, electrically stimulated [Ca 2ϩ ] i transients, and contraction in response to TNF-␣ in isolated cardiomyocytes obtained from rats that were given the glutathione precursor N-acetylcysteine (NAC).
Methods

Cardiomyocyte Isolation
The care and the use of the animals were in accordance with institutional guidelines. Adult, male Wistar rats (180 to 250 g, Janvier, LeGenest St Isle, France) were used. Calcium-tolerant myocytes were isolated by cardiac retrograde aortic perfusion as described by Delcayre et al. 13 Freshly isolated cardiomyocytes were plated on laminin (3 g/mL; Sigma) and cultured for up to 2 days according to Sambrano et al. 14 When indicated, rats were treated with NAC (Sigma) administered twice intraperitoneally (100 mg per animal), 48 and 24 hours before anesthesia. As shown in Figure 3 , exogenously added GSH 10 mmol/L did not affect the response of cardiomyocytes to electrical stimulation either in the basal state or in the presence of TNF-␣. Thus, to avoid possible leakage of cellular GSH, 10 mmol/L GSH was added to the heart perfusion, cardiomyocyte attachment, fura 2-AM loading, and [Ca 2ϩ ] i imaging media when cardiomyocytes were obtained from NAC-treated rats.
Measurement of [Ca 2؉ ] i Transients and Cell Fractional Shortening
Plating of cardiomyocytes on laminin, loading with fura 2-AM (Molecular Probes), field electrical stimulation (square waves, 0.5 Hz), [Ca 2ϩ ] i imaging, and fractional shortening were performed as previously described. 7, 15 Results are shown as meanϮSEM for 5 to 10 cells obtained from 3 different isolations, or as typical.
Measurement of Intracellular ROS
Cardiomyocytes attached on laminin (10 5 cells per 2-cm-diameter dish) were loaded with 5 mol/L 2N,7N-dichlorodihydrofluorescein diacetate (H 2 DCF-DA) (Molecular Probes) in the conditions described for fura 2-AM loading. 7, 15 DCF fluorescence was recorded at an excitation wavelength of 480 nm and a 510-nm filter. 16 Data are expressed as percent of the maximal effect produced by 3.5 mmol/L H 2 O 2 and are meanϮSEM for 5 to 10 cells obtained from 3 different isolations.
N-SMase Activity
Cardiomyocytes attached on laminin (6.5ϫ10 5 cells per 9-cmdiameter dish) were bathed at 37°C in a saline buffer (mmol/L: glucose 10, NaCl 130, KCl 5, HEPES 50, pH 7.4, MgCl 2 1, CaCl 2 2), with or without 25 ng/mL TNF-␣. After 30 minutes, cells were harvested by scraping and frozen in liquid nitrogen. Aliquots were assayed for N-SMase activity as previously described. 17 Values are meanϮSEM for 3 to 5 isolations.
Analysis of Site-Specific Phospholamban Phosphorylation in Isolated Hearts
Hearts were perfused in the Langendorff mode with a modified Krebs-Henseleit perfusion medium containing (mmol/L) NaCl 135, KCl 4.75, KH 2 PO 4 1.19, Na 2 HPO 4 16, NaHCO 3 25, sucrose 134, HEPES 10, and glucose 10, gassed with 95% O 2 /5% CO 2 (pH 7.4, 37°C). When stated, 1 mol/L isoproterenol (Sigma) for 2 minutes or TNF-␣ (Peprotech Inc) at varying concentrations and for 10 minutes was added to the perfusion medium. Left ventricles were homogenized at 4°C with an Ultra-Turrax T25 (Janke-Kunkel) in buffer containing (mmol/L) Tris-HCl 10, pH 7.4, Na 4 P 2 O 7 10, sucrose 300, dithiothreitol 1, vanadate 0.4, phenylmethanesulfonyl fluoride 0.3, and NaF 50. Homogenates were centrifuged at 8000g for 20 minutes.
For Western blot analysis, supernatant proteins were solubilized in Laemmli loading buffer, boiled for 5 minutes, and resolved with 18% SDS-polyacrylamide gels using a 6% stacking gel. Proteins were transferred to polyvinylidene difluoride membranes (0.22 m, Millipore) by electroblotting. Membranes were next incubated with the primary antibodies P-Ser 16 -or P-Thr 17 -phospholamban (PLB) (1:1250 dilution; Cyclacel Ltd), then with peroxidase-conjugated donkey anti-rabbit IgG (1:5000 dilution, Jackson Immunoresearch). The peroxidase activity was visualized with an enhanced chemiluminescent detection kit, ECL PLUS (Amersham Biosciences). Loading and protein transfers were verified with a mouse actin antibody (AC 15, Sigma).
Dot blots were performed for quantification of PLB phosphorylation with 0.22-m nitrocellulose membrane (Schleicher and Schuell). For standardization, samples (0.03 to 2.5 g proteins) of pooled ventricular tissues obtained from hearts perfused with 1 mol/L isoproterenol for 2 minutes were applied in parallel. Immunodetection of phosphorylated PLB was performed as described above for the Western blots. P-Ser 16 -or P-Thr 17 -PLB was quantified by scanning densitometry (NIH image 1.6; David Chow and Jai Evans) and calculated from the standard curve established with isoproterenol samples, the 2.5-g sample of isoproterenol being taken as 100%. Values are meanϮSEM for 3 to 5 hearts.
Measurement of Total Glutathione Content in Heart
Total glutathione (GSHϩGSSG) was measured according to a modification of the method of Tietze. 18 Values are meanϮSEM for 3 hearts.
Statistical Analysis
Results were analyzed by the Student 2-tailed t test or repeatedmeasures ANOVA and post hoc multiple comparison testing between control and treatment groups (Dunnett test), as appropriate. Differences were considered statistically significant at a value of PϽ0.05.
Results
NAC Treatment Increases GSH Content in the Heart
NAC treatment (100 mg IP per animal, administered twice, 48 and 24 hours before anesthesia) increased cardiac GSHϩGSSG by 42Ϯ6% (PϽ0.05), suggesting that NAC augmented the buffering capacity against oxidative stress of the heart (Table 1) . Values for total glutathione (GSHϩGSSG) are meanϮSEM obtained from 3 hearts. For N-SMase activity and ROS generation, cardiomyocytes isolated from control or NAC-treated rats were attached on laminin and exposed to saline buffer with or without 25 ng/mL TNF-*PϽ0.05 vs basal values. †PϽ0.05 vs corresponding value of control rats. 11, 19 Taken together, those findings support the proposal that NAC treatment can antagonize cell responses to TNF-␣.
NAC Treatment Blunts ROS Generation and N-SMase Activation Elicited by TNF-␣
NAC Treatment Abrogates the Negative Inotropic Effect of TNF-␣ and Unmasks a Positive Effect
We have previously reported that TNF-␣ exerted a dual, positive and negative, effect on [Ca 2ϩ ] i transients. 7 At 10 ng/mL, TNF-␣ increased the amplitude of [Ca 2ϩ ] i transients in cardiomyocytes obtained from control hearts (24Ϯ8% over control after 20 minutes, PϽ0.05, Figure 1A ). In contrast, at higher concentrations (Ն25 ng/mL), TNF-␣ decreased the amplitude of [Ca 2ϩ ] i transients (22Ϯ6% below control levels, PϽ0.05). The negative effect of 25 ng/mL TNF-␣ was significant after 10 minutes and developed for Ն30 minutes ( Figure 1B ). As also shown in Figure 1 , not only the negative effect of high TNF-␣ concentrations on [Ca 2ϩ ] i transients was abrogated in electrically stimulated cardiomyocytes 7 obtained from NAC-treated rats, but a positive effect was also unmasked. After 20 minutes of perfusion, 25 to 50 ng/mL TNF-␣ increased the amplitude of [Ca 2ϩ ] i transients by 40% to 50% over basal (PϽ0.05) ( Figure 1A) . The positive effect of TNF-␣ was detected from 10 minutes and developed for at least 30 minutes ( Figure 1B) . The typical traces of [Ca 2ϩ ] i transients and fractional shortening in Figure 2 show the correlation between the increase in the amplitude of [Ca 2ϩ ] i transients and that of contraction in cardiomyocytes obtained from hearts of NAC-treated rats electrically stimulated and exposed to TNF-␣. After 20 minutes of exposure to 25 ng/mL TNF-␣, the amplitudes of [Ca 2ϩ ] i transients and fractional shortening were increased by 40% over the control value at time zero. Maximal 2-to 3-fold increases over basal were observed after 30 minutes ( Figure 2 ). The positive inotropic effect of TNF-␣ was associated with a lusitropic potency ( Table 2 ). After 30 minutes of exposure to 25 ng/mL TNF-␣, the decay half-times (t 1/2 ) of both [Ca 2ϩ ] i transients (480Ϯ37 versus 609Ϯ35 ms, PϽ0.05) and contraction (486Ϯ12 ms versus 614Ϯ32 ms, PϽ0.05) were reduced to Ϸ80% of the basal values. Times to peak were reduced similarly (PϽ0.05; Table 2 ). It should be noted that oxidative stress induced by H 2 O 2 (200 mol/L) abrogated the positive effect of TNF-␣ on the amplitude of [Ca 2ϩ ] i transients and contraction in cardiomyocytes obtained from NAC-treated rats (not shown).
In Isolated Cardiomyocytes, Exogenously Added S-Methylglutathione Reproduced the Effects of In Vivo NAC Treatment
We asked whether the effects of NAC treatment relied on the increase in total cellular glutathione content rather than on cell redox status. Therefore, we examined the effects of 2-to 3-hour preincubations with either antioxidants or the gluta-thione donor S-methylglutathione (GSM) on the response to TNF-␣ of isolated cardiomyocytes obtained from control rats. Butylated hydroxyanisol (10 mol/L) and vitamin E (1 g/mL) blunted the negative effect of 25 ng/mL TNF-␣ on the amplitude of electrically stimulated [Ca 2ϩ ] i transients (PϽ0.05; Figure 3 ). Nevertheless, neither antioxidant unmasked a positive effect of TNF-␣ at high concentrations.
Conversely, glutathione repletion, achieved with 50 mol/L GSM, did reproduce the effects of in vivo NAC treatment, unmasking a positive effect of 25 ng/mL TNF-␣ (ϩ50Ϯ0.17%, PϽ0.05; Figure 3 ). GSM had no effect on the amplitude of basal (Figure 3) . Thus, although a positive effect on [Ca 2ϩ ] i transients was observed with TNF-␣ after preincubation with NAC, this effect could not be considered a specific TNF-␣ effect. These data show that only the in vitro preincubation with the glutathione donor GSM could reproduce the in vivo effect of NAC.
NAC Treatment Promotes PLB Phosphorylation by TNF-␣
Relaxation depends on the activity of the sarcoplasmic reticulum Ca 2ϩ -ATPase, the activity of which is essentially controlled by its inhibitor dephosphorylated PLB. Phosphorylation of PLB reverses this inhibition, thereby accelerating Ca 2ϩ uptake into the sarcoplasmic reticulum and facilitating cardiac relaxation. 20 In response to ␤-adrenergic stimulation in vivo, PLB is phosphorylated at 2 adjacent amino residues, Ser 16 and Thr 17 . 21, 22 We looked for PLB phosphorylation as a possible component of the positive effect of TNF-␣. Because phosphorylation of the Thr 17 -PLB residue depends on the beating state of the cardiomyocyte, 22 the experiments were performed on isolated, spontaneously beating, perfused hearts obtained from rats treated or not with NAC. The heart was perfused with medium with or without either 1 mol/L isoproterenol for 2 minutes or with 10 or 25 ng/mL TNF-␣ for 10 minutes. Figure 4 shows typical Western blots of site- specific Ser 16 -and Thr 17 -PLB phosphorylation induced by TNF-␣ and quantification of the effects assessed by densitometric evaluations of dot blots. In control hearts, TNF-␣ had no significant effect on the phosphorylation of either Ser 16 -or Thr 17 -PLB residues. NAC treatment also did not significantly affect basal phosphorylation of Ser 16 and Thr 17 residues. In contrast, in hearts obtained from NAC-treated rats, 10 to 25 ng/mL TNF-␣ produced a dramatic increase in the phosphorylation of both Ser 16 -and Thr 17 -PLB residues (ϩ260Ϯ70%, PϽ0.05, and ϩ115Ϯ10% of isoproterenol, PϽ0.05, respectively, Figure 4 ).
Discussion
The new findings of this study are twofold. First, in vivo administration of NAC, which increases heart glutathione content, protects isolated cardiomyocytes against ROS generation and the negative effect of [Ca 2ϩ ] i transients and contraction produced by high TNF-␣ concentrations. Second, such an anti-TNF-␣ action of NAC is related to N-SMase inhibition.
Because it is a key player in the maintenance of cell antioxidant status, glutathione and its precursor NAC are generally matched with antioxidants. Clearly, a distinction should be made between the total cellular glutathione content and antioxidant status. Indeed, the decreases in both glutathione content and antioxidant status, related to an increase in oxidative stress, are crucial elements in the pathogenesis of heart failure. However, glutathione has other, nonrelated antioxidant effects. Thus, reduced as well as oxidized glutathione inhibits N-SMase activity. 23 Accordingly, only glutathione replenishment can compensate for glutathione depletion. Indeed, when added exogenously to isolated cardiomyocytes, only the glutathione donor GSM could reproduce the effects of in vivo NAC treatment. NAC added in vitro, which does not increase glutathione content in normoxic isolated cardiomyocytes, 24 solely shifts the negative contractile effect of TNF-␣ to a null effect, as do the antioxidants butylated hydroxyanisol and vitamin E. Taken together, these data support the proposal that the effects of NAC in vivo treatment described here (1) are caused by the conversion of NAC into glutathione and are not imputable to a NAC byproduct and (2) are linked to an increase in glutathione content rather than a scavenging of antioxidants.
A previous study on rat neonatal cardiomyocytes showed that TNF-␣ inhibited isoproterenol-induced PLB phosphorylation by stimulating the ceramide-activated phosphatase, phosphatase 2A. 25 We show here that the beneficial effect of NAC treatment is related to an increase in PLB phosphorylation in response to TNF-␣. Because NAC treatment triggers N-SMase inhibition, an increase in PLB phosphorylation might result from phosphatase 2A inhibition caused by a drop in ceramide. This highlights the implication of ceramide, in addition to sphingosine, and further strengthens the role of N-SMase in the negative contractile effect of TNF-␣.
In summary, the present study shows that administration of NAC suppresses the deleterious effect of TNF-␣ on heart contraction. Importantly, NAC also inhibits the nuclear factor-B-dependent cardiac hypertrophic response to TNF-␣. 26 Taken together, those findings point out the unique property of NAC in antagonizing 2 major components of heart failure. However, the limitation of this study is that it addresses the protective effect of NAC against the acute negative inotropic effects of TNF-␣. The long-term beneficial effects of NAC treatment in animal models of developing heart failure remain to be investigated. Nevertheless, the absence of functional data does not detract from the fact that NAC abrogates TNF-␣ effects deleterious to cardiomyocytes, a finding that raises the possibility of a new therapeutic option for human heart failure, consistent with the administration of NAC to minimize the impact of reperfusion injury in the treatment of acute myocardial infarction. 27 In conclusion, NAC might be regarded as a more general therapeutic tool for the management of vulnerable, aging, or failing hearts that are particularly exposed to TNF-␣. Figure 4 . TNF-␣ triggers Ser 16 -PLB and Thr 17 -PLB phosphorylation in NAC-treated rat hearts. Hearts obtained from control rats were perfused with either 1 mol/L isoproterenol for 2 minutes or indicated concentration of TNF-␣ for 10 minutes. Hearts obtained from NAC-treated rats were perfused for 10 minutes with perfusion medium added with 10 mmol/L GSH and indicated concentration of TNF-␣. A, Autoradiograms are representative of Western blots probed with specific P-Ser 16 -or P-Thr 17 -PLB antibodies (left and right, respectively), each lane representing a separate isolated rat heart. B, Densitometric evaluations of dot blots probed with specific P-Ser 16 -or P-Thr 17 -PLB antibodies (left and right, respectively) are expressed as percentage of 1 mol/L isoproterenol-induced Ser 16 -or Thr 17 -PLB phosphorylation, respectively, and are meanϮSEM of 3 to 5 different hearts. *PϽ0.05 vs basal value; †PϽ0.05 vs corresponding control rat.
